Selective impairments in the stress response in schizophrenic patients

Psychopharmacology

Volumn 149, Issue 3, 2000, Pages 319-325

  Jansen, Lucres M C ^a   Gispen de Wied, Christine C ^a   Kahn, René S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coping; Cortisol; Exercise; Hypothalamic pituitary adrenal system; Psychological stress; Schizophrenia

Indexed keywords

ARGIPRESSIN; DEXAMETHASONE; HYDROCORTISONE;

ADAPTIVE BEHAVIOR; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; EXERCISE TEST; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SALIVA; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL;

EID: 0034019118     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000381     Document Type: Article

References (38)

1. Albus M, Ackenheilo M, Engel RR, Muller F (1982) Situational reactivity of autonomic functions in schizophrenic patients. Psychiatry Res 6:361-370
2. Andreasen NC, Flaum M, Arndt S (1992) The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing psychopathology and diagnosis. Arch Gen Psychiatry 49:615-623
3. Bohnen N, Nicolson N, Sulon J, Jolles J (1991) Coping style, trait anxiety and cortisol reactivity during mental stress. J Psychosom Med 35:141-147
4. Brambilla F, Facchinetti F, Petraglia F, Vanzulli L, Genazzani AR (1984) Secretion pattern of endogenous opioids in chronic schizophrenia. Am J Psychiatry 141:1183-1189
5. Breier A (1989) A. E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol Psychiatry 26:438-462
6. Breier A, Wolkowitz OM, Doran AR, Bellar S, Pickar D (1988) Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Res 25:187-194
7. De Kloet ER (1991) Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95-164
8. Elman I, Adler CM, Malhotra AK, Bir C, Pickar D, Breier A (1998) Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. Am J Psychiatry 155:979-981
9. Endicott J, Spitzer RL (1978) Diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844
10. Folkman S, Lazarus RS (1985) If it changes it must be a process; a study of emotion and coping during three stages of a college examination. J Person Soc Psychol 48:150-170
11. Gispen-de Wied CC, Westenberg HG, Thijssen JH, Van Ree JM (1987) The dexamethasone and cortisol suppression test in depression: beta-endorphin as a useful marker. Psychoneuroendocrinology 12:355-366
12. Gispen-de Wied CC, Jansen LMC, Wynne HJ, Matthys W, Van der Gaag RJ, Thijssen JHH, Van Engeland H (1998) Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric population. Psychoneuroendocrinology 23:295-305
13. Jansen LMC, Gispen-de Wied CC, Gademan PJ, De Jonge RCJ, Van der Linden JA, Kahn RS (1998) Blunted cortisol response to a psychosocial Stressor in schizophrenia. Schizophr Res 33:87-94
14. Kathol RG, Gehris TL, Carroll BT, Samuelson SD, Pitts AF, Meller WH, Carter JL (1992) Blunted ACTH response to hypoglycemic stress in depressed patients but not in patients with schizophrenia. J Psychiatr Res 26:103-116
15. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome rating scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276
16. Kemali D, Maj M, Ariano MG, Arena F, Lovero N (1985) 24-Hour plasma levels of prolactin, cortisol, growth hormone and catecholamines in scizophrenic patients. Neuropsychobiology 14:109-114
17. Kirschbaum C, Hellhammer DH (1994) Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19:313-333
18. Kudoh A, Kudo T, Ishihara H, Matsuki A (1997) Depressed pituitary-adrenal response to surgical stress in chronic schizophrenic patients. Neuropsychobiology 36:112-116
19. Marx CE, Lieberman JA (1998) Psychoneuroendocrinology of schizophrenia. Psychiatr Clin N Am 21:413-434
20. Meador-Woodruff JH, Greden JF (1988) Effects of psychotrophic medications on hypothalamic-pituitary-adrenal regulation. Endocrinol Neuropsychiatr Disord 6:225-234
21. Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotoninhypothesis of schizophrenia. Psychopharmacology 99:S18-S27
22. Norman RMG, Malla AK (1994) A prospective study of daily Stressors and symptomatology in schizophrenic patients. Soc Psychiatr Psychiatr Epidemiol 29:244-249
23. Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J (1992) Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 18:387-425
24. Nuechterlein KH, Dawson ME, Ventura J, Gitlin M, Subotnik KL, Snyder KS, Mintz J, Bartzokis G (1994) The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl 382:58-64
25. Rao ML, Strebel B, Halaris A, Gross G, Braunig P, Huber G, Marler M (1995) Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia. Psychiatry Res 57:21-39
26. Rechlin T, Claus D, Weis M (1994) Heart rate variability in schizophrenic patients and changes of autonomie heart rate parameters during treatment with clozapine. Biol Psychiatry 35: 888-892
27. Risch SC, Lewine RJ, Kalin NH, Jewart RD, Risby ED, Caudle JM, Stipetic M, Turner J, Eccard MB, Pollard WE (1992) Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia. Neuropsychopharmacology 6:95-100
28. Romero LM, Sapolsky RM (1996) Patterns of ACTH secretagog secretion in response to psychological stimuli. J Neuroendocrinol 8:243-258
29. Roy A, Pickar D, Doran A, Wolkowitz O, Gallucci W, Chrousos G, Gold P (1986) The corticotropin-releasing hormone stimulation test in chronic schizophrenia. Am J Psychiatry 143: 1393-1397
30. Schreurs PJG, Tellegen B, Van de Willige G (1984) Gezondheid, stress en coping: de ontwikkeling van de Utrechtse Coping Lijst. Tijdschr Psychol 12:101-117
31. Tandon R, Mazzara C, DeQuardo J, Craig KA, Meador Woodruff JH, Goldman R, Greden JF (1991) Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 29: 953-964
32. Van Cauter E, Linkowski P, Kerkhofs M, Hubain P, L'Hermite-Baleriaux M, Leclerq R, Brasseur M, Copinschi G, Mendlewicz J (1991) Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry 48:348-356
33. Van den Bosch RJ, Van Asma MJO, Rombouts R, Louwerens JW (1992) Coping style and cognitive dysfunction in schizophrenic patients. Br J Psychiatry 161:123-128
34. Van der Ploeg HM, Defares PB, Spielberger CD (1981) Handleiding bij de zelf-beoordelingsvragenlijst. Swets and Zeitlinger BV, Lisse
35. Wik G (1995) Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. J Endocrinol 144:425-429
36. Yank GR, Bentley KJ, Hargrove DS (1993) The vulnerability-stress model of schizophrenia: advances in psychosocial treatment. Am J Orthopsychiatry 63:55-69
37. Yeragani VK (1990) The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls. Can J Psychiatry 35:128-132
38. Zahn TP, Pickar D (1993) Autonomie effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biol Psychiatry 34:3-12